Clinical Trials Browser

Phase 4 × OTHER × tenofovir alafenamide × Clear all

NCT04619082 2024-11-12

TAF to Prevent HBV Reactivation in Cancer Patients

Phase 4 Active not recruiting

Hepatitis B Reactivation

NCT06221657 2024-01-24

Clinical Trial for Non-inferiority and Safety of Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in Patients With Hematologic Malignancies Who Require Prophylactic Hepatitis B Antiviral Treatment

Phase 4 Not yet recruiting

Patients With Malignant Blood Disease Requiring Hepatitis B Antiviral Medication